Ranu Biswas

Dr. Ranu Biswas

orcid
Associate Professor, Dept. of Pharmaceutical Technology, Jad...

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2025 in Molecules
Verified
Journal Article
Open access
PDF file
Ranu BiswasRanu Biswas
Ranu Biswas
SMSourav Mondal
Sourav Mondal
AAAhesan Ansari
Ahesan Ansari
Tanima SarkarTanima Sarkar
Tanima Sarkar
ISIustina Petra Solomon-Condriuc
Iustina Petra Solomon-Condriuc
Leonard Ionut AtanaseLeonard Ionut Atanase
Leonard Ionut Atanase
Chitosan (CS) occurs naturally as an alkaline polysaccharide and has been demonstrated to have several activities of a biological nature. Additionally, as CS chains have functional hydroxyl and amino groups that are active, their applications can be expanded by chemically or molecularly altering the molecules to incorporate new functional groups. Due to its outstanding qualities, including biodegradability, biocompatibility, non-toxicity, and accessibility, it has received significant interest in all areas of biomedicine and nanomaterials being extremely promising as drug nanocarrier. The last decades have produced a lot of interest in CS-based nanoparticles (CSNPs), with an increasing number of research papers from around 1500 in 2015 to almost 5000 in 2024. The degree of crosslinking, the particulate system’s shape, size, and density, in addition to the drug’s physical and chemical properties, all have a role in how the drug is transported and released from CSNPs. When creating potential drug delivery systems based on CSNPs, all these factors must be considered. In earlier, CSNPs were employed to enhance the pharmacotherapeutics, pharmacokinetics, and solubility properties of drugs. By investigating its positively charged characteristics and changeable functional groups, CS has evolved into a versatile drug delivery system. The drug release from CSNPs will definitely be influenced by various changes to the functional groups, charges, and polymer backbone. This review mainly discusses the most important results published in the last decade. Despite the promising advantages of CSNPs, challenges related to the translation into clinical stages remain and further in vitro and in vivo studies are mandatory.
1

9 December 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SSShounak Sarkhel
Shounak Sarkhel
SSSaikat Mollick Shuvo
Saikat Mollick Shuvo
AAAhesan Ansari
Ahesan Ansari
SMSourav Mondal
Sourav Mondal
PKPritam Kapat
Pritam Kapat
ACAlexandru Carauleanu
Alexandru Carauleanu
Diabetes is a widespread metabolic illness. Mismanagement of diabetes can lead to severe complications that tremendously impact patients’ quality of life. The assimilation of nanotechnology in diabetes care holds the potential to revolutionize treatment paradigms, improve patient outcomes, and reduce the economic burden associated with this pervasive disease. This manuscript explores the multifaceted utilization of nanomaterials in diabetes care, emphasizing the unique features of nano-based medication delivery methods and smart drug delivery mechanisms. Additionally, this paper talks about research on nanocarrier-integrated oral, transdermal, and inhalable insulin delivery; dendrimer- and nanocarrier-coupled antisense oligonucleotide-driven gene therapy; the implementation of gold nanoparticles and quantum dots for glucose surveillance; and nucleic acid therapies. There are certain restrictions when using medication delivery methods that are commonly available to handle diabetes. In order to increase efficacy and safety, the rapidly developing science of nanotechnology is also being explored and employed in medical biology. Nanomaterials like liposomes, dendrimers, niosomes, polymeric and metallic nanocarriers, and solid lipid nanoparticles are among the nanocarriers that have been developed for better delivery of various oral hypoglycemic agents in comparison to conventional therapies. These nanocarriers provide great control over elevated blood glucose levels, making them one of the most intriguing and promising technologies available today. Furthermore, adding additional ligands to nanocarriers allows for more focused distribution while protecting the encapsulated hypoglycemic drugs.

7 October 2018 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
Ranu BiswasRanu Biswas
Ranu Biswas
KSKalyan Kumar Sen
Kalyan Kumar Sen
Objective: Diabetes, the “third killer” of mankind, is now a global burden affecting nearly 10% of the population. The present study aimed at pharmacognostical evaluation of Syzygium cumini seed powder, phytochemical profiling, total phenolic, and flavonoid content determination and to ascertain its antioxidant activity and hypoglycemic potential in alloxan-induced diabetic rats.Methods: Pharmacognostical and physicochemical parameters of the seed powder were determined by using standard methods as per Ayurvedic Pharmacopoeia of India (API). In vitro antioxidant activity was determined by 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity. Ethanolic extract of Syzygium cumini seed at a dose of 200mg/kg and 400mg/kg body weight (bw) were given orally in alloxan-induced (150mg/kg, i.p) diabetic rats daily for three weeks.Results: physicochemical parameters complied with the API standards. Phytochemical profiling revealed that the extract contains phenolic compounds, flavonoids, glycosides, alkaloids, tannins, and saponins. The extract is rich in phenolic compounds which were 177.33 mg gallic acid equivalent/g (GAE/g dry weight) and showed significant percentage inhibition compared to standard ascorbic acid. The extract reduced the fasting blood sugar (FBS) level by 46.67–52.67% which is very close to the standard drug glibenclamide (reduced FBS by 65.58%). It also improved the bw by 18.20–20.41% after extract treatment where the standard drug increased the bw by 22.95% of the diabetic rats.Conclusion: In conclusion, Syzygium cumini seed extract is rich in phenolic compounds. Results suggested that the extract possesses significant radical (DPPH) scavenging activity and FBS lowering potential in alloxan-induced diabetic rats.

20 June 2024 in Acta Chimica Slovenica
Verified
Journal Article
Open access
PDF file
SRSK MOSIUR RAHAMAN
SK MOSIUR RAHAMAN
GDGouranga Dutta
Gouranga Dutta
Ranu BiswasRanu Biswas
Ranu Biswas
ASABIMANYU SUGUMARAN
ABIMANYU SUGUMARAN
MSMohamed M Salem
Mohamed M Salem
MSMounir M. Salem-Bekhit
Mounir M. Salem-Bekhit
Diabetes mellitus is a chronic metabolic disorder marked by elevated blood sugar levels, leading to organ dysfunction. Curcumin, derived from turmeric, exhibits promise in managing type II diabetes. Amphipathic polymer prodrugs were synthesized by conjugating curcumin with chitosan through succinic anhydride. Nanomicelles, formed via dialysis of amphipathic polymer prodrug, were spherical with an average hydrodynamic size of 57 nm. In vitro release studies revealed 97% curcumin release at pH 5 in 7 days. A 21-day experiment on diabetic mice compared nano micelles, standard drugs, and free curcumin’s impact on fasting blood glucose. The study showcased gradual, controlled curcumin release from nano micelles, suggesting their potential in type II diabetes treatment.

1 July 2025 in International Journal of Pharmacy and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
Ranu BiswasRanu Biswas
Ranu Biswas
PKPritam Kapat
Pritam Kapat
AGArindam Ghosh
Arindam Ghosh
SSShounak Sarkhel
Shounak Sarkhel
Tanima SarkarTanima Sarkar
Tanima Sarkar
DDDipankar DAS
Dipankar DAS
Polymers have significantly assisted to the advancement of the drug delivery devices by adjusting the drug release at consistent rates over extended durations, facilitating cyclic administration, and targeting to the desired site. Polymers are frequently utilized as taste-masking, stabilizing, and proactive agents. The key characteristics that render polymers appealing options for drug delivery include their safety, effectiveness, hydrophilicity, non-immunogenicity, biological inertness, favourable pharmaceutical kinetics, and the presence of functional groups that facilitate covalent crosslinking, targeting ligands, or copolymer formation. Natural polymers that are more commonly used, like arginine, collagen, chitosan, and carrageenans are discussed for their possible application in polymeric drug delivery systems. Synthetic polymers exhibit elevated immunogenicity, limiting their viability for prolonged application. Non-biodegradable polymers necessitate subsequent removal post-drug release at the intended site. Progress in polymer science has made possible in the emergence of various innovative drug delivery systems, including hydrogels, liposomes, nanoparticles, micelles, patches, implants, and others. Biodegradable polymers have garnered considerable interest because they can degrade into non-toxic monomers, enabling sustained drug release from biodegradable polymer-based controlled-release devices. This review delves into the commonly used synthetic and natural polymers that are used in drug delivery, consideration of selection of polymers and recent advancement in polymer research.

7 May 2024 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
SRSk Mosiur Rahaman
Sk Mosiur Rahaman
ACAtanu Chandra
Atanu Chandra
Ranu BiswasRanu Biswas
Ranu Biswas
Objective: To develop a reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous estimation of conjugated form of Curcumin (CCMN) and free form of Resveratrol (RSV) in nano-micelle. Methods: The conjugation of lipophilic CCMN and hydrophilic Chitosan (CHT) through succinyl linker produce amphipathic molecule that can self-assemble into RSV solution to form micelle. Here RSV exists in micelle core as free form and CCMN with micelle backbone as conjugated form. So it required to estimate conjugated drug and free drug simultaneously from nano-micelle. We developed a RP-HPLC method, utilized C18 column, follow flow rate of mobile phase 1.0 ml/min, which consist of acetonitrile with water (0.5% Ortho Phosphoric acid, pH 4.6) in the ratio of 1:1 for 20 min. Injection volume was 10μl and column temperature 25 ℃. Isosbestic detection of both drugs was at 254 nm. Results: The retention time of RSV and CCMN were at 8.15 min and 11.41 min respectively, completely distinguished sharp peak of CCMN and RSV developed with resolution 7.360±0.117, wide range of linearity with correlation coefficient value (R2) of CCMN and RSV were 0.99987 and 0.99992 respectively and recovery value of CCMN and RSV were 100.041±0.22 % and 100.041±0.21 % respectively. The RSD (relative standard deviation) for accuracy, precision and robustness of the method was found to be less than 2%. Conclusion: The develop method for simultaneous estimation of conjugated CCMN and free form of RSV in the nano-micelle formulation was consider to be accurate, precise, robust and sensitive.